AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
13.36
-0.01 (-0.07%)
At close: Oct 13, 2026, 4:00 PM EDT
13.33
-0.03 (-0.25%)
After-hours: Oct 13, 2026, 7:52 PM EDT
AVITA Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Strong Buy" and an average price target of $13.47. The average 1-year stock price forecast is 0.82% higher than the current stock price, while the lowest is $11.67 (-12.65%) and the highest is $15.04 (+12.57%).
Price Target: $13.47 (+0.82%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AVITA Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $11 → $15 | Buy | Maintains | $11 → $15 | +12.28% | Oct 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $14 | Buy | Maintains | $14 | +4.79% | Sep 18, 2026 |
| Lake Street | Lake Street | Buy Reiterates $12 | Buy | Reiterates | $12 | -10.18% | Aug 28, 2026 |
Financial Forecast
Revenue This Year
88.35M
from 71.61M
Increased by 23.37%
Revenue Next Year
114.74M
from 88.35M
Increased by 29.87%
EPS This Year
-0.92
from -1.74
EPS Next Year
-0.40
from -0.92
EPS and Forward PE are based on non-GAAP adjusted numbers.